MRNA vs. WBA
MRNA (Moderna, Inc.) and WBA (Walgreens Boots Alliance, Inc.) are both stocks. Both are in the Healthcare sector — MRNA in Biotechnology, WBA in Pharmaceutical Retailers. At a 0.20 correlation, their price movements are largely independent.
Performance
MRNA vs. WBA - Performance Comparison
Loading charts...
Returns By Period
MRNA
- 1D
- 0.54%
- 1M
- 1.77%
- YTD
- 69.24%
- 6M
- 69.42%
- 1Y
- 87.14%
- 3Y*
- -26.94%
- 5Y*
- -25.59%
- 10Y*
- —
WBA
- 1D
- —
- 1M
- —
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
MRNA vs. WBA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
MRNA Moderna, Inc. | 69.24% | -29.08% | -58.19% | -44.63% | -29.28% | 143.11% | 434.10% | 28.09% | -30.59% |
WBA Walgreens Boots Alliance, Inc. | 0.00% | 28.40% | -61.34% | -25.09% | -25.06% | 35.78% | -29.38% | -10.99% | -17.62% |
Correlation
The correlation between MRNA and WBA is -0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.03 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.24 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.22 |
Correlation (All Time) Calculated using the full available price history since Dec 7, 2018 | 0.20 |
The correlation between MRNA and WBA shifts across timeframes, from -0.03 (1 year) to 0.24 (3 years), reflecting how their relationship changes across market environments.
Fundamentals
MRNA:
$2.23B
WBA:
$154.58B
MRNA:
-$309.00M
WBA:
$26.47B
MRNA:
-$3.02B
WBA:
-$2.92B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MRNA vs. WBA — Risk / Return Rank
MRNA
WBA
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
MRNA vs. WBA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Moderna, Inc. (MRNA) and Walgreens Boots Alliance, Inc. (WBA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MRNA | WBA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.24 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 2.34 | — | — |
| Martin ratioReturn relative to average drawdown | 4.59 | — | — |
Loading charts...
Drawdowns
MRNA vs. WBA - Drawdown Comparison
Loading charts...
Drawdown Indicators
| MRNA | WBA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.38% | — | — |
Max Drawdown (1Y)Largest decline over 1 year | -35.51% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -86.58% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -95.38% | — | — |
Current DrawdownCurrent decline from peak | -89.70% | — | — |
Average DrawdownAverage peak-to-trough decline | -57.06% | — | — |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 18.06% | — | — |
Volatility
MRNA vs. WBA - Volatility Comparison
Loading charts...
Volatility by Period
| MRNA | WBA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.56% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 48.82% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 64.75% | — | — |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 66.49% | — | — |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 72.15% | — | — |
Dividends
MRNA vs. WBA - Dividend Comparison
Neither MRNA nor WBA has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MRNA Moderna, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
WBA Walgreens Boots Alliance, Inc. | 0.00% | 0.00% | 10.72% | 7.35% | 5.13% | 3.62% | 4.64% | 3.04% | 2.46% | 2.13% | 1.78% | 1.64% |
Financials
MRNA vs. WBA - Financials Comparison
This section allows you to compare key financial metrics between Moderna, Inc. and Walgreens Boots Alliance, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
MRNA and WBA have a correlation of -0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for MRNA and WBA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer